Loading company…
Shandong Buchang Pharmaceuticals develops, produces, and sells traditional Chinese medicines.
Founded in 2001, Shandong Buchang Pharmaceuticals researches, develops, produces, and sells Chinese patent medicines, including Naoxintong Capsules, Wenxin Granules, and Danhong Injection. Its products address cardiovascular and cerebrovascular conditions. Based in Xian, China, the company raised CNY 66 million in Series F funding from Brightstone Venture Capital in August 2011 and listed on the Shanghai Stock Exchange in November 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in